Israel Englander Harmony Biosciences Holdings, Inc. Call Options Transaction History

Millennium Management LLC

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q2 2023 Aug 14, 2023	BUY	$30.5 - $37.4 $643,550 - $789,140	21,100 Added 52.75%	61,100 $2.15 Million
Q1 2023 May 15, 2023	BUY	$30.8 - $53.92 $1.23 Million - $2.16 Million	40,000 New	40,000 $1.31 Million

255

46.7M

119K

50K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.